We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The device is used during coronary angiography procedures to help physicians make clinical decisions without the need for another intervention. Read More
“The nefarious tactics that drug companies use to influence state Medicaid programs’ drug coverage decisions are dishonest and disturbing,” said Booker. Read More
Under the agreement, Philips has agreed to continue service until Dec 31, 2022, and it will meet with the TGA twice yearly and report adverse events as required under normal operations. Read More
In October 2017, Sanofi launched patent infringement litigation against Mylan’s NDA for generic versions of its Lantus vials and disposable injection pens. That litigation is still pending, with no trial date assigned. Read More
Baldwin called for detailed data on the price hikes, noting that in the wake of the 2017 tax reform bill, Pfizer received nearly $11 billion in tax benefits, almost all of which went to stock buybacks. Read More